Nephrology Dialysis Transplantation · 2024 · 12 citations · 30 references
Life SciencesImmunologyNephrologyCellular ImmunologyImmunopathologyMucosal ImmunologyAutoimmune DiseasesB Cell ActivationB Cell BiologyB Cell DevelopmentHumoral ImmunityRenal ImmunopathologyAntibodiesB Cell DysfunctionB-cell Mediated Renal AutoimmunityB-cell PathogenesisCell ActivationFlow Cytometry ImmunophenotypingImmunoglobulin A NephropathyMucosal B Cells
BACKGROUND: Immunoglobulin A nephropathy (IgAN) is characterized by the production of galactose-deficient IgA1 (GdIgA1) antibodies. As the source of pathogenic antibodies, B cells are central to IgAN pathogenesis, but the B cell activation pathways as well as the potential B cell source of dysregulated IgA secretion remain unknown. METHODS: We carried out flow cytometry analysis of peripheral blood B cells in patients with IgAN and control subjects with a focus on IgA-expressing B cells to uncover the pathways of B cell activation in IgAN and how these could give rise to pathogenic GdIgA1 antibodies. RESULTS: In addition to global changes in the B cell landscape-expansion of naïve and reduction in memory B cells-IgAN patients present with an increased frequency of IgA-expressing B cells that lack the classical memory marker CD27, but are CD21+. IgAN patients furthermore have an expanded population of IgA+ antibody-secreting cells, which correlate with serum IgA levels. Both IgA+ plasmabalsts and CD27- B cells co-express GdIgA1. Implicating dysregulation at mucosal surfaces as the driver of such B cell differentiation, we found a correlation between lipopolysaccharide in the serum and IgA+CD27- B cell frequency. CONCLUSION: We propose that dysregulated immunity in the mucosa may drive de novo B cell activation within germinal centres, giving rise to IgA+CD27- B cells and subsequently IgA-producing plasmablasts. These data integrate B cells into the paradigm of IgAN pathogenesis and allow further investigation of this pathway to uncover biomarkers and develop therapeutic interventions.
30
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Zina Moldoveanu, Robert Wyatt, J.Y. Lee et al. · Kidney International · 2007 · 417 citations
Medicine, Immunology, Nephrology +14
Richard Lafayette, Jens Kristensen, Andrew Stone et al. · The Lancet · 2023 · 289 citations · Full text
Medicine, Nephrology, Pharmacology +12